1 – 20 of 40
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Baseline breast tissue characteristics determine the effect of tamoxifen on mammographic density change
2024) In International Journal of Cancer(
- Contribution to journal › Article
-
Mark
Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit
(
- Contribution to journal › Article
- 2023
-
Mark
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer : data from the randomized SBII:2 trial
(
- Contribution to journal › Article
-
Mark
CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer.
(
- Contribution to journal › Article
-
Mark
Effects of tamoxifen on normal breast tissue histological composition : Results from a randomised six-arm placebo-controlled trial in healthy women
(
- Contribution to journal › Article
- 2022
-
Mark
GPR30 in breast cancer - from molecular mechanisms to clinical outcome
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2021
-
Mark
CYP2D6 genotype predicts tamoxifen discontinuation and drug response : a secondary analysis of the KARISMA trial
(
- Contribution to journal › Article
-
Mark
Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer : data from a randomised trial with long-term follow-up
(
- Contribution to journal › Article
-
Mark
Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis
(
- Contribution to journal › Article
- 2019
-
Mark
Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial
(
- Contribution to journal › Article
- 2018
-
Mark
Prognostic and Predictive Markers in Primary Breast Cancer - Quality Assurance and Long-term Effects of Adjuvant tamoxifen Treatment
2018)(
- Thesis › Doctoral thesis (compilation)
- 2017
-
Mark
Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer : the Danish cohort of BIG 1-98
(
- Contribution to journal › Article
- 2016
-
Mark
4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
(
- Contribution to journal › Article
-
Mark
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
(
- Contribution to journal › Article
-
Mark
Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera
(
- Contribution to journal › Article
- 2015
-
Mark
Tamoxifen treated patients have a better survival than patients treated with aromatase inhibitors - A population based registry study in Sweden
(
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
Cell cycle deregulation in breast cancer subgroups and effects on proliferation, migration and tamoxifen resistance
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up
(
- Contribution to journal › Article
- 2012
-
Mark
Predicting Prognosis and Tamoxifen Response in Breast Cancer. With a special focus on contralateral breast cancer.
(
- Thesis › Doctoral thesis (compilation)